Indian Repaglinide Exporters: Complete Supplier Ranking with Market Share — 41 Manufacturers (2026) — TransData Nexus

Q: Who is the largest repaglinide supplier from India?

AUROBINDO PHARMA LTD is the largest repaglinide exporter from India with a 51.4% market share and export value of $3.6M.

Q: How many repaglinide suppliers are there in India?

There are 41 active repaglinide exporters in India, collectively shipping $6.9M worth of repaglinide across 819 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top repaglinide suppliers from India?

The top 5 repaglinide suppliers from India — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, USV PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 98.5% of total repaglinide export value from India.

Suresh Sormare

Repaglinide

India Pharmaceutical Trade Intelligence

$6.9M41 Suppliers36 CountriesHS 30049099

ExportsIndia → UNITED STATES60.4%India → FRANCE15.7%

ImportsGERMANY → India$167.2M DENMARK → India$185.9K

#1 Buyer: AUROLOGISTICS LLC

Repaglinide Suppliers from India (2026) — 41 Exporters, $6.9M Market | TransData Nexus | TransData Nexus

Who Exports Repaglinide from India — 41 Suppliers Behind a $6.9M Market

India's repaglinide export market is supplied by 41 active exporters who collectively shipped $6.9M across 819 shipments. AUROBINDO PHARMA LTD leads with a 51.4% market share, followed by AUROBINDO PHARMA LIMITED and USV PRIVATE LIMITED. The top 5 suppliers together control 98.5% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Repaglinide Suppliers & Exporters — 41 manufacturers, $6.9M export market, top destinations and formulations — Repaglinide supplier data — 41 exporters · $6.9M market · 819 shipmentsTransData Nexus · Indian Customs Data

Top Repaglinide Exporters from India — Ranked by Export Value

AUROBINDO PHARMA LTD is the leading repaglinide exporter from India, holding a 51.4% share of the $6.9M market across 819 shipments from 41 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, USV PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD — collectively control 98.5% of total export value, indicating a highly concentrated market. Individual shares are: AUROBINDO PHARMA LTD (51.4%), AUROBINDO PHARMA LIMITED (25.5%), USV PRIVATE LIMITED (12.8%), INTAS PHARMACEUTICALS LIMITED (5.0%), MACLEODS PHARMACEUTICALS LTD (3.9%).

Top Repaglinide Exporters from India

Ranked by export value · 41 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Repaglinide Exporters from India — Ranked by Export Value. 41 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Repaglinide exporters

Certification and compliance status for top Repaglinide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Approved	Yes (March 2024)	Yes	89	WHO GMP compliance accepted for Unit IV in March 2024.
Intas Pharmaceuticals Limited	Approved	Yes (April 2007)	Yes	89	First Indian company to receive EU GMP certification in April 2007.
Macleods Pharmaceuticals Ltd	Approved	Yes	Yes	Not specified	Holds US DMF for Prasugrel Hydrochloride.

TransData Nexus reviewed the regulatory standing of 3 leading Repaglinide exporters from India. 3 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Repaglinide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for active pharmaceutical ingredient (API) production. The city contributes approximately 40% of the country's bulk drug output, underscoring its significance in the pharmaceutical supply chain. This prominence is bolstered by the presence of Hyderabad Pharma City, an expansive industrial park dedicated to pharmaceutical manufacturing and research. The park aims to position Hyderabad as a global leader in pharma and biotech innovation, fostering a sustainable and eco-friendly environment that aligns with global standards.

Notably, Aurobindo Pharma Limited, headquartered in Hyderabad, is a major exporter of Repaglinide, accounting for 51.4% of total exports valued at $3.6 million. The company's strategic location within this cluster facilitates efficient production and distribution of APIs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat leads India with a 33% share in drug manufacturing and a 28% share in drug exports. The region hosts numerous USFDA-certified manufacturing facilities, reflecting its adherence to international quality standards.

Companies like Intas Pharmaceuticals Limited, based in Ahmedabad, contribute significantly to the export of Repaglinide, holding a 5.0% share valued at $0.3 million. The cluster's emphasis on formulations ensures a steady supply of finished pharmaceutical products to global markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Repaglinide exporters from India

July 2025

M&A

Aurobindo Pharma Limited — Aurobindo Pharma acquires Lannett Company for $250 million

Aurobindo Pharma's US subsidiary entered a definitive agreement to acquire Lannett Company LLC, a US-based generic pharmaceuticals manufacturer, for $250 million. This acquisition aims to expand Aurobindo's US manufacturing capacity and portfolio, particularly in ADHD therapies and complex controlled substances. The transaction is subject to US FTC and regulatory approval and is expected to close within 8-12 months. - IMPACT: This acquisition is anticipated to enhance Aurobindo's production capabilities, potentially increasing Repaglinide exports.

Impact: This acquisition is anticipated to enhance Aurobindo's production capabilities, potentially increasing Repaglinide exports.

November 2024

Collaboration

Aurobindo Pharma Limited — Aurobindo Pharma USA collaborates with global pharma major on respiratory products

Aurobindo Pharma USA Inc., a wholly owned subsidiary of Aurobindo Pharma, entered into a collaboration and license agreement with an unnamed global pharmaceutical company for the development and commercialization of specific products in the respiratory therapeutic area. The agreement spans an initial estimated development duration of three to five years, with both parties co-exclusively commercializing the products. Aurobindo committed to an upfront payment of $25 million and a cost-sharing arrangement capped at $90 million over the development period. - IMPACT: While focused on respiratory products, this collaboration may free up resources within Aurobindo, potentially benefiting Repaglinide production and exports.

Common Questions — Repaglinide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which repaglinide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 265 recorded shipments worth $3.6M. AUROBINDO PHARMA LIMITED (136 shipments) and USV PRIVATE LIMITED (46 shipments) are also established high-volume exporters.

Q How many repaglinide manufacturers are there in India?

India has 41 active repaglinide exporters with a combined export market of $6.9M across 819 shipments to 36 countries. The top 5 suppliers hold 98.5% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for repaglinide from India?

Average FOB unit price: $1.54 per unit, ranging from $0.00 to $54.95. Average shipment value: $8.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Repaglinide

Repaglinide

Who Exports Repaglinide from India — 41 Suppliers Behind a $6.9M Market

Top Repaglinide Exporters from India — Ranked by Export Value

Top Repaglinide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Limited — Aurobindo Pharma acquires Lannett Company for $250 million

Aurobindo Pharma Limited — Aurobindo Pharma USA collaborates with global pharma major on respiratory products

Common Questions — Repaglinide Suppliers from India

Q Which repaglinide supplier from India is the most reliable for bulk orders?

Q How many repaglinide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for repaglinide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Aurobindo Pharma Limited — Aurobindo Pharma acquires Khandelwal Labs' non-oncology prescription business for ₹325 crore

Analysis Methodology